Jaya Real Property Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Jaya Real Property Tbk. trades at Rp1,115 (market cap 14.52T, 867.1K 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Jaya Real Property Tbk. is far larger — about 139.1× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| JRPT | SCPI | |
|---|---|---|
Market Cap | 14.52T | 104.4B |
Volume | 867.1K | — |
Lot | 8.67K | — |
Turnover | 961.9M | — |
Average Price | 1,109.32 | — |
Value | 961.9M | — |
Indicative Equilibrium Price | 1,115 | — |
Indicative Equilibrium Volume | 2.5K | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Jaya Real Property Tbk (the Company) was established under Domestic Investment Law on May 25, 1979, based on the notarial deed No. 36 of Hobropoerwanto, S.H., at that time a notary in Jakarta, and amended with notarial deed No. 14 of the same notary as of December 6, 1979.. Jaya Real Property is the largest property company (in terms of market capitalization) listed on the JSX. It is a wholly owned subsidiary of PT Pembangunan Jaya (the Jaya Group), which is the oldest established property developer.
Read more on JRPT →PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →